511 results on '"Branda, John A."'
Search Results
2. Borrelia-specific antibody profiles and complement deposition in joint fluid distinguish antibiotic-refractory from -responsive Lyme arthritis
3. Fun with fungi: a comprehensive review of common fungal organisms encountered in cytology
4. Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants
5. Severe antigen excess confounding the detection ofPlasmodium falciparumvia rapid antigen assay
6. Clinical Performance of Cas13a-based Point-of-Care Lateral Flow Assay for DetectingNeisseria gonorrhoeae
7. Intrathecal inflammatory responses in the absence of SARS-CoV-2 nucleic acid in the CSF of COVID-19 hospitalized patients
8. Ehrlichiosis and anaplasmosis subcommittee report to the Tick-borne Disease Working Group
9. Adaptive adversarial neural networks for the analysis of lossy and domain-shifted datasets of medical images
10. Laboratory Testing for Powassan Virus: Past, Present, and Future.
11. Comparative Evaluation of Commercial Test Kits Cleared for Use in Modified Two-Tiered Testing Algorithms for Serodiagnosis of Lyme Disease.
12. Second Time's the Charm? Assessing the Sensitivity and Yield of Inpatient Diagnostic Algorithms for Pulmonary Tuberculosis in a Low-Prevalence Setting.
13. Higher C6 enzyme immunoassay index values correlate with a diagnosis of noncutaneous Lyme disease
14. Dematiaceous fungal infections: clinical and pathologic conundrums.
15. 255. Borrelia-specific antibody profiling in joint fluid distinguishes antibiotic-refractory Lyme arthritis from antibiotic-responsive arthritis
16. Author Correction: Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants
17. Development of Cas13a-based assays for Neisseria gonorrhoeae detection and gyrase A determination
18. Advances in Serodiagnostic Testing for Lyme Disease Are at Hand
19. Reply to Naktin
20. Utilization Management in the Clinical Microbiology Laboratory
21. Evaluation of a sequential enzyme immunoassay testing algorithm for Lyme disease demonstrates lack of test independence but high diagnostic specificity
22. Pediatric Lyme Disease Biobank, United States, 2015-2020
23. Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme Disease
24. Whole genome sequencing of human Borrelia burgdorferi isolates reveals linked blocks of accessory genome elements located on plasmids and associated with human dissemination
25. Evaluation of the rapid Quidel Sofia Lyme fluorescent immunoassay as a first-tier test in a modified 2-tier testing algorithm for Lyme disease: A comparison with the Zeus ELISA Borrelia VlsE1/pepC10 lgG/IgM assay followed by the Zeus monovalent IgM/IgG confirmatory assay
26. Development of Cas13a-based Assays for Neisseria gonorrhoeae Detection and Gyrase A Determination
27. Evaluation of the Rapid Quidel Sofia 2 Lyme Immunoassay as a First-Tier Test in a Two-Tier Testing Algorithm for Lyme Disease: Comparison to the Zeus ELISA Borrelia VlsE1/pepC10 IgG/IgM Assay Followed by Immunoblot
28. Evaluation of the C6 Lyme Enzyme Immunoassay for the Diagnosis of Lyme Disease in Children and Adolescents
29. Positive Two-tiered Lyme Disease Serology is Uncommon in Asymptomatic Children Living in Endemic Areas of the U.S.
30. Whole genome sequencing ofBorrelia burgdorferiisolates reveals linked clusters of plasmid-borne accessory genome elements associated with virulence
31. Babesia microti variant with multiple resistance mutations detected in an immunocompromised patient receiving atovaquone prophylaxis
32. Babesia microti with multiple resistance mutations detected in an immunocompromised patient receiving atovaquone prophylaxis
33. Using CSF Proteomics to Investigate Herpesvirus Infections of the Central Nervous System
34. Poor Positive Predictive Value of Lyme Disease Serologic Testing in an Area of Low Disease Incidence
35. Vasculopathy and Increased Vascular Congestion in Fatal COVID-19 and Acute Respiratory Distress Syndrome
36. Utilization Management in the Clinical Microbiology Laboratory
37. Case 22-2022: A 34-Year-Old Woman with Cavitary Lung Lesions
38. Lyme neuroborreliosis: known knowns, known unknowns
39. Performance of United States Serologic Assays in the Diagnosis of Lyme Borreliosis Acquired in Europe
40. Multicenter Clinical Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Using Zeus Scientific Commercial Assays
41. Intrathecal inflammatory responses in the absence of SARS-CoV-2 nucleic acid in the CSF of COVID-19 hospitalized patients (S18.004)
42. The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine Recipients
43. Two-Tiered Antibody Testing for Lyme Disease With Use of 2 Enzyme Immunoassays, a Whole-Cell Sonicate Enzyme Immunoassay Followed by a VlsE C6 Peptide Enzyme Immunoassay
44. 2-Tiered Antibody Testing for Early and Late Lyme Disease Using Only an Immunoglobulin G Blot with the Addition of a VlsE Band as the Second-Tier Test
45. Sensitivity of Two-Tiered Lyme Disease Serology in Children With an Erythema Migrans Lesion.
46. Lyme borreliosis
47. MALDI-TOF Mass Spectrometry in the Clinical Microbiology Laboratory
48. Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and SARS-CoV-2 variants
49. Case 28-2015: A Man with Febrile Symptoms after Traveling from Liberia
50. Case 32–2015: A 57-Year-Old Man with Severe Pneumonia and Hypoxemic Respiratory Failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.